Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials

JAMA Psychiatry (2013) - Comments
pubmed: 23986353 doi: 10.1001/jamapsychiatry.2013.149 issn: 2168-6238 issn: 2168-622x

Arif Khan, James Faucett, Shaneta Morrison, Walter A. Brown